{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T13:57:39Z","timestamp":1791640659953,"version":"4.3.4"},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pancreatology"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.pan.2018.11.001","type":"journal-article","created":{"date-parts":[[2018,11,10]],"date-time":"2018-11-10T11:56:52Z","timestamp":1541851012000},"page":"127-135","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":92,"title":["Sarcopenia is a reliable prognostic factor in patients with advanced pancreatic cancer receiving FOLFIRINOX chemotherapy"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2482-6707","authenticated-orcid":false,"given":"Yusuke","family":"Kurita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noritoshi","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motohiko","family":"Tokuhisa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayumu","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensuke","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itaru","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Ichikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pan.2018.11.001_bib1","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(04)15841-8","article-title":"Pancreatic cancer","volume":"363","author":"Li","year":"2004","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.pan.2018.11.001_bib2","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1056\/NEJMra0901557","article-title":"Pancreatic cancer","volume":"362","author":"Hidalgo","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pan.2018.11.001_bib3","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","article-title":"Folfirinox versus gemcitabine for metastatic pancreatic cancer","volume":"364","author":"Conroy","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pan.2018.11.001_bib4","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0149-2918(05)80001-3","article-title":"Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern cooperative oncology group","volume":"69","author":"Dewys","year":"1980","journal-title":"Am J Med"},{"key":"10.1016\/j.pan.2018.11.001_bib5","doi-asserted-by":"crossref","first-page":"6973","DOI":"10.1158\/1078-0432.CCR-09-1525","article-title":"Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer","volume":"15","author":"Tan","year":"2009","journal-title":"Clin Canc Res"},{"key":"10.1016\/j.pan.2018.11.001_bib6","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.surg.2015.08.047","article-title":"Impact of the preoperative quantity and quality of skeletal muscle on outcomes after resection of extrahepatic biliary malignancies","volume":"159","author":"Okumura","year":"2016","journal-title":"Surgery"},{"key":"10.1016\/j.pan.2018.11.001_bib7","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.clnu.2015.08.005","article-title":"The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer or distal cholangiocarcinoma","volume":"35","author":"Rollins","year":"2016","journal-title":"Clin Nutr"},{"key":"10.1016\/j.pan.2018.11.001_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0139749","article-title":"Skeletal muscle depletion predicts the prognosis of patients with advanced pancreatic cancer undergoing palliative chemotherapy, independent of body mass index","volume":"10","author":"Choi","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.pan.2018.11.001_bib9","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s10637-013-0053-6","article-title":"Low skeletal muscle is associated with toxicity in patients included in phase i trials","volume":"32","author":"Cousin","year":"2014","journal-title":"Invest N Drugs"},{"key":"10.1016\/j.pan.2018.11.001_bib10","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1158\/1078-0432.CCR-08-2242","article-title":"Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment","volume":"15","author":"Prado","year":"2009","journal-title":"Clin Canc Res"},{"key":"10.1016\/j.pan.2018.11.001_bib11","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.4143\/crt.2015.250","article-title":"Prognostic factors for risk stratification of patients with recurrent or metastatic pancreatic adenocarcinoma who were treated with gemcitabine-based chemotherapy","volume":"48","author":"Park","year":"2016","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.pan.2018.11.001_bib12","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s00432-012-1371-3","article-title":"Prognostic value of ca 19-9, cea, crp, ldh and bilirubin levels in locally advanced and metastatic pancreatic cancer: results from a multicenter, pooled analysis of patients receiving palliative chemotherapy","volume":"139","author":"Haas","year":"2013","journal-title":"J\u00a0Canc Res Clin Oncol"},{"key":"10.1016\/j.pan.2018.11.001_bib13","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1007\/s00280-014-2450-8","article-title":"Serum levels of ldh, cea, and ca19-9 have prognostic roles on survival in patients with metastatic pancreatic cancer receiving gemcitabine-based chemotherapy","volume":"73","author":"Tas","year":"2014","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.pan.2018.11.001_bib14","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1111\/j.1440-1746.2009.05935.x","article-title":"Can preoperative ca19-9 and cea levels predict the resectability of patients with pancreatic adenocarcinoma?","volume":"24","author":"Kim","year":"2009","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.pan.2018.11.001_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0163064","article-title":"Systemic inflammatory response and elevated tumour markers predict worse survival in resectable pancreatic ductal adenocarcinoma","volume":"11","author":"Salmiheimo","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.pan.2018.11.001_bib16","first-page":"1001","article-title":"Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients","volume":"85","author":"Onodera","year":"1984","journal-title":"Nihon Geka Gakkai zasshi"},{"key":"10.1016\/j.pan.2018.11.001_bib17","first-page":"53","article-title":"Adipose tissue volume determinations in women by computed tomography: technical considerations","volume":"10","author":"Kvist","year":"1986","journal-title":"Int J Obes"},{"key":"10.1016\/j.pan.2018.11.001_bib18","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jhep.2015.02.031","article-title":"Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma","volume":"63","author":"Fujiwara","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.pan.2018.11.001_bib19","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1470-2045(08)70153-0","article-title":"Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study","volume":"9","author":"Prado","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.pan.2018.11.001_bib20","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00535-014-0964-9","article-title":"Skeletal muscle depletion is an independent prognostic factor for hepatocellular carcinoma","volume":"50","author":"Iritani","year":"2015","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.pan.2018.11.001_bib21","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2147\/CMAR.S126073","article-title":"Comparative effectiveness and resource utilization of nab-paclitaxel plus gemcitabine vs folfirinox or gemcitabine for the first-line treatment of metastatic pancreatic adenocarcinoma in a us community setting","volume":"9","author":"Braiteh","year":"2017","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.pan.2018.11.001_bib22","doi-asserted-by":"crossref","first-page":"808","DOI":"10.21037\/jgo.2017.06.11","article-title":"Impact of sarcopenia on outcomes of locally advanced esophageal cancer patients treated with neoadjuvant chemoradiation followed by surgery","volume":"8","author":"Murimwa","year":"2017","journal-title":"J\u00a0Gastrointest Oncol"},{"key":"10.1016\/j.pan.2018.11.001_bib23","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1503\/cmaj.1031527","article-title":"An approach to the management of unintentional weight loss in elderly people","volume":"172","author":"Alibhai","year":"2005","journal-title":"CMAJ: Can Med Assoc J"},{"key":"10.1016\/j.pan.2018.11.001_bib24","first-page":"1861","article-title":"Folfirinox in locally advanced and metastatic pancreatic cancer: a single centre cohort study","volume":"7","author":"Rombouts","year":"2016","journal-title":"J\u00a0Canc"},{"key":"10.1016\/j.pan.2018.11.001_bib25","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1007\/s11605-010-1213-z","article-title":"A\u00a0single institution review of adjuvant therapy outcomes for resectable pancreatic adenocarcinoma: outcome and prognostic indicators","volume":"14","author":"Kim","year":"2010","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1016\/j.pan.2018.11.001_bib26","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1007\/s13277-015-3851-y","article-title":"The predictive value of alkaline phosphatase and lactate dehydrogenase for overall survival in patients with esophageal squamous cell carcinoma","volume":"37","author":"Wei","year":"2016","journal-title":"Tumour Biol: J Int Soc Oncodevelopment Biol Med"},{"key":"10.1016\/j.pan.2018.11.001_bib27","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.urolonc.2010.07.002","article-title":"Serum alkaline phosphatase changes predict survival independent of psa changes in men with castration-resistant prostate cancer and bone metastasis receiving chemotherapy","volume":"30","author":"Sonpavde","year":"2012","journal-title":"Urol Oncol"},{"key":"10.1016\/j.pan.2018.11.001_bib28","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/sj.bjc.6604568","article-title":"Modelling prognostic factors in advanced pancreatic cancer","volume":"99","author":"Stocken","year":"2008","journal-title":"Br J Canc"},{"key":"10.1016\/j.pan.2018.11.001_bib29","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/MPA.0000000000000465","article-title":"C-reactive protein level is an indicator of the aggressiveness of advanced pancreatic cancer","volume":"45","author":"Mitsunaga","year":"2016","journal-title":"Pancreas"},{"key":"10.1016\/j.pan.2018.11.001_bib30","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1007\/s11605-012-1923-5","article-title":"Impact of sarcopenia on outcomes following resection of pancreatic adenocarcinoma","volume":"16","author":"Peng","year":"2012","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1016\/j.pan.2018.11.001_bib31","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1007\/s11605-015-2835-y","article-title":"Impact total psoas volume on short- and long-term outcomes in patients undergoing curative resection for pancreatic adenocarcinoma: a new tool to assess sarcopenia","volume":"19","author":"Amini","year":"2015","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1016\/j.pan.2018.11.001_bib32","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1200\/JCO.2012.45.2722","article-title":"Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index","volume":"31","author":"Martin","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pan.2018.11.001_bib33","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/bjs.7823","article-title":"Body composition and outcome in patients undergoing resection of colorectal liver metastases","volume":"99","author":"van Vledder","year":"2012","journal-title":"Br J Surg"},{"key":"10.1016\/j.pan.2018.11.001_bib34","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s12603-011-0088-3","article-title":"Are current definitions of sarcopenia applicable for older Chinese adults?","volume":"15","author":"Wen","year":"2011","journal-title":"J\u00a0Nutr Health Aging"},{"key":"10.1016\/j.pan.2018.11.001_bib35","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jamda.2013.11.025","article-title":"Sarcopenia in asia: consensus report of the asian working group for sarcopenia","volume":"15","author":"Chen","year":"2014","journal-title":"J\u00a0Am Med Dir Assoc"},{"key":"10.1016\/j.pan.2018.11.001_bib36","doi-asserted-by":"crossref","first-page":"102474","DOI":"10.18632\/oncotarget.19687","article-title":"Clinical significance of sarcopenia in the treatment of patients with primary hepatic malignancies, a systematic review and meta-analysis","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.pan.2018.11.001_bib37","first-page":"1","article-title":"Assessment of body composition and sarcopenia in patients with esophageal cancer: a systematic review and meta-analysis","volume":"31","author":"Boshier","year":"2018","journal-title":"Dis Esophagus"}],"container-title":["Pancreatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1424390318307464?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1424390318307464?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T16:08:23Z","timestamp":1761408503000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1424390318307464"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S1424390318307464"],"URL":"https:\/\/doi.org\/10.1016\/j.pan.2018.11.001","relation":{},"ISSN":["1424-3903"],"issn-type":[{"value":"1424-3903","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sarcopenia is a reliable prognostic factor in patients with advanced pancreatic cancer receiving FOLFIRINOX chemotherapy","name":"articletitle","label":"Article Title"},{"value":"Pancreatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pan.2018.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier B.V. on behalf of IAP and EPC.","name":"copyright","label":"Copyright"}]}}